ITech Medical Appoints Vice President of Sales and Marketing
ITech Medical (OTCBB: IMSU), iTech Medical Announces Appoints New Vice President - Keywords: healthcare, biomedical, wellness, back pain, neck pain, neurology, medical device, clinical studies, commercialization
Huntington Beach, CA (Vocus) September 22, 2010
iTech Medical, Inc. (OTCBB: IMSU (http://www. otcbb. com/profiles/imsu. htm), FWB: 0IM (http://www. quote. com/global/stocks/quote. action? s=0IM-FRA&fromSearch=true)), a medical information technology company, today announced the appointment of Karl R. Wolcott as Vice President of Sales and Marketing. In this new capacity, Mr. Wolcott is charged with developing and implementing strategic initiatives to begin sales of the MPR System throughout the Americas, Europe, and Asia. He will report directly to Wayne Cockburn, President and CEO at iTech Medical.
“We’re very pleased to welcome Karl to iTech Medical (http://www. itechmedical. com) at this time,” said Mr. Cockburn. “Karl has more than 25 years experience in the medical device and medical software industry. His addition to our executive management team is a continuation of our organizational development strategy and is a reflection of our transition into the area of commercialization and sales. Karl’s proven success in building and expanding global sales channels made him our top choice. With Karl’s healthcare experience, expertise and leadership ability, we are confident he will be a key contributor to our future growth and development."
"It's very exciting to be joining the iTech Medical team," said Karl Wolcott. "This is an exceptional opportunity for me to leverage my experience in cultivating strategic distribution partnerships for the purpose of developing MPR sales, building significant market share within key targeted business sectors, and elevating our industry relationship marketing strategies to the next level. I am committed to identifying growth opportunities for our technology, building awareness of iTech Medical’s capabilities, and helping the company achieve its revenue objectives."
About Karl Wolcott
Karl Wolcott is an accomplished sales and marketing executive with proven success in driving dynamic growth for global companies including Picker International, a former Marconi Medical Systems company, a $1.6B manufacturer / marketer of medical imaging equipment and distributor of imaging supplies and accessories. As Corporate Vice President, Business Development and Integrations, Wolcott led a multi-disciplinary team to evaluate growth opportunities for new Information Technology product and service offerings to complement core business product portfolio. As Vice President and General Manager, Health Care Products Division, a $535M, nine hundred employee business units, Wolcott was directly responsible for all business operations including two manufacturing plants as well as selling and distributing imaging supplies, accessories, ancillary capital equipment, and image management products. Other prominent medical experience includes Vice President, Global Sales and Marketing - Microbiology Division for AccuMed International Inc. and Chief Operating Officer for Ridgeway Biosystems Inc.
About iTech Medical
ITech Medical, Inc. (OTCBB: IMSU, FWB: 0IM) is engaged in the research and commercial development of healthcare information systems and technologies. To date, the Company has focused on developing a proprietary platform called Muscle Pattern Recognition (http://www. itechmedical. com/itechnology. htm) (MPR), a unique clinical tool for the analysis of muscle function. MPR is a patented clinical tool that analyzes patterns of muscle recruitment. It provides detailed physiological information on muscle function that can assist in the diagnosis and treatment of back and neck injuries and illness.
For the latest information on iTech Medical, please visit our website at http://www. iTechMedical. com (http://www. iTechMedical. com)
Forward-Looking and Cautionary Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that reflect management’s current views and estimates regarding future market conditions, company performance and financial results, business prospects, new strategies, the competitive environment and other events. You can identify these statements by the fact that they use words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “project,” “plan,” “outlook,” and other words and terms of similar meaning.
These statements involve a number of risks and uncertainties that could cause actual results to materially differ from the potential results discussed in the forward-looking statements. Among the factors that could cause actual results and outcomes to differ materially from those contained in such forward-looking statements are the following: general economic conditions, acquisitions and development of new businesses, divestitures, product availability, sales volumes, pricing actions and promotional activities of our competitors, profit margins, weather, changes in law or regulations, foreign currency fluctuation, availability of suitable real estate locations, our ability to react to a disaster recovery situation, and the impact of labor markets and new product introductions on our overall profitability.
A further list and description of these risks, uncertainties and other matters can be found in the company’s annual report and other reports filed from time to time with the Securities and Exchange Commission, including, but not limited to, iTech Medical’s Annual Report on Form 10-K filed with the SEC on April 15, 2010. iTech Medical cautions that the foregoing list of important factors is not complete and assumes no obligation to update any forward-looking statements that it may make.
Dianemarie (DM) Collins
DM Productions LLC
775.825.1727 (Reno, NV Office) 623.825.9122 (Phoenix, AZ Office)
Wayne Cockburn, CEO
ITech Medical, Inc.
714.841.2670 (Huntington Beach, CA Office) 905.505.0770 (Montreal, CDA Office)
# # #